BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31215818)

  • 1. Emerging gene therapies for cystic fibrosis.
    Miah KM; Hyde SC; Gill DR
    Expert Rev Respir Med; 2019 Aug; 13(8):709-725. PubMed ID: 31215818
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in gene therapy for cystic fibrosis lung disease.
    Yan Z; McCray PB; Engelhardt JF
    Hum Mol Genet; 2019 Oct; 28(R1):R88-R94. PubMed ID: 31332440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy in cystic fibrosis.
    Flotte TR; Laube BL
    Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
    Southern KW; Patel S; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Zhou ZP; Yang LL; Cao H; Chen ZR; Zhang Y; Wen XY; Hu J
    Hum Gene Ther; 2019 Sep; 30(9):1101-1116. PubMed ID: 31099266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic therapies for cystic fibrosis lung disease.
    Sinn PL; Anthony RM; McCray PB
    Hum Mol Genet; 2011 Apr; 20(R1):R79-86. PubMed ID: 21422098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease.
    Marquez Loza LI; Yuen EC; McCray PB
    Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30875857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Editing for Cystic Fibrosis.
    Wang G
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
    Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
    Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches to genetic therapies for cystic fibrosis.
    Christopher Boyd A; Guo S; Huang L; Kerem B; Oren YS; Walker AJ; Hart SL
    J Cyst Fibros; 2020 Mar; 19 Suppl 1():S54-S59. PubMed ID: 31948871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and novel therapeutic strategies for the management of cystic fibrosis.
    Gbian DL; Omri A
    Expert Opin Drug Deliv; 2021 May; 18(5):535-552. PubMed ID: 33426936
    [No Abstract]   [Full Text] [Related]  

  • 12. Delivery of genes into the CF airway.
    Gill DR; Hyde SC
    Thorax; 2014 Oct; 69(10):962-4. PubMed ID: 25015239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on Genetic Medicine for Cystic Fibrosis.
    Smirnikhina SA
    Curr Gene Ther; 2022; 22(5):386-396. PubMed ID: 35864800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene and Base Editing as a Therapeutic Option for Cystic Fibrosis-Learning from Other Diseases.
    Mention K; Santos L; Harrison PT
    Genes (Basel); 2019 May; 10(5):. PubMed ID: 31117296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines.
    Turuvekere Vittala Murthy N; Vlasova K; Renner J; Jozic A; Sahay G
    Adv Drug Deliv Rev; 2024 Jun; 209():115305. PubMed ID: 38626860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging technologies for cystic fibrosis transmembrane conductance regulator restoration in all people with CF.
    Egan ME
    Pediatr Pulmonol; 2021 Feb; 56 Suppl 1(Suppl 1):S32-S39. PubMed ID: 32681713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming Immunological Challenges to Helper-Dependent Adenoviral Vector-Mediated Long-Term
    Cao H; Duan R; Hu J
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32443586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond cystic fibrosis transmembrane conductance regulator therapy: a perspective on gene therapy and small molecule treatment for cystic fibrosis.
    Schneider-Futschik EK
    Gene Ther; 2019 Sep; 26(9):354-362. PubMed ID: 31300729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.
    Tang Y; Yan Z; Engelhardt JF
    Hum Gene Ther; 2020 May; 31(9-10):524-537. PubMed ID: 32138545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Modulator Therapies: Developing a Therapy for Every Cystic Fibrosis Patient.
    Egan ME
    Clin Chest Med; 2022 Dec; 43(4):717-725. PubMed ID: 36344076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.